Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Clinical trial NCT05228275 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05228275
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

COVID-19 Infection Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Start date: 2022-04-08
Primary completion: 2027-09-30
Enrollment: 549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.